Third Time's the Charm: FDA Approves Replimune's Tudriqev (RP1) for Advanced Melanoma
Who Will Write the Next Chapter of Oncology? – CancerWorld
ORR vs OS: The Debate Continues on X
Sequencing After Enfortumab Vedotin and Pembrolizumab in Advanced Urothelial Carcinoma
Patient Advocate Training Opportunity
Cancer Research Funding: Underfunded or Unequally Distributed?
A Living Library of Cancer: New Models Could Help Researchers Find Better Treatments
Metastatic Renal Cell Carcinoma in 2026: Frontline Combinations, Post-IO Sequencing, and the Emergence of HIF-2α Inhibition
The San Antonio Breast Cancer Symposium (SABCS) 2026 will take place on 8–11 December 2026 at the Henry B. González Convention Center in San Antonio, Texas, with both in-person and virtual participation available. The symposium brings together more than 11,000 physicians, researchers, clinicians, and patient advocates from over 100 countries, making it one of the […]
